Osteomyelitis: Clinical Trials

12 trials for Osteomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 2 unknown, 2 withdrawn. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 3, Recruiting 3, Unknown 2, Withdrawn 2, Not yet recruiting 1, Terminated 1

Follow Osteomyelitis: new trials by email Literature Review of Osteomyelitis trials Research Report on Osteomyelitis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot
Oral Beta-Lactam Antibiotic, Oral Non-Beta-Lactam Antibiotic - Osteomyelitis of Lower Extremities, Osteomyelitis - Foot
Phase 4RecruitingMichael Garron Hospital14182026-02-262026-03-27
Antibiotic Impregnated Beads in Osteomyelitis
Antibiotic loaded calcium sulfate beads, Calcium sulfate beads (sham beads) - Osteomyelitis of the Foot, Antibiotic Impregnated Beads
Phase 4Not yet recruitingUniversity of Arizona1002025-09-012025-07-18
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Trimethoprim Sulfamethoxazole - Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute
Phase 4RecruitingIndiana University1002025-05-202026-07-29
BonE and Joint Infections - Simplifying Treatment in Children Trial
Oral cefalexin only, IV cefazolin or IV flucloxacillin followed by oral cefalexin - Bone Infection, Septic Arthritis
Phase 4RecruitingMurdoch Childrens Research Institute2142021-06-012026-10-27
Oral-only Antibiotics for Bone and Joint Infections in Children
Oral co-amoxiclav or oral dicloxacillin only, IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin - Osteomyelitis, Septic Arthritis
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet1802020-09-152025-04-13
Ceftriaxone as Home IV for Staph Infections
Ceftriaxone, Usual Antibiotics (Cloxacillin, Cefazolin, Daptomycin) - Staphylococcal Infections, Osteomyelitis
Phase 4UnknownVancouver Island Health Authority3102019-07-112019-10-28
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
Dalbavancin, Vancomycin - Bone Infection, Osteomyelitis
Phase 4CompletedInfectious Diseases Physicians, Inc.412018-01-252023-10-03
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
Rifampin, Riboflavin Placebo - Osteomyelitis, Diabetes
Phase 4CompletedVA Office of Research and Development8432018-01-222026-04-20
CERAMENT™|G - Bone Healing and Re-infection Prophylaxis
Cerament G - Osteomyelitis
Phase 4UnknownDr. Olivier Borens152014-05-012015-12-02
Ceftaroline in the Treatment of Bone and Joint Infections
Ceftaroline - Osteomyelitis, Joint Infections
Phase 4WithdrawnOrlando Health, Inc.2013-04-012014-08-07
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
Vancomycin, Ceftaroline, Daptomycin - Health Care Associated Pneumonia, Osteomyelitis/Septic Arthritis
Phase 4TerminatedHenry Ford Health System1002011-10-012023-05-03
a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis
Medical/surgical treatment versus medical treatment - Diabetic Foot
Phase 4WithdrawnAssistance Publique - Hôpitaux de Paris2008-06-012012-09-17

Narrower conditions

Arthritis, Infectious (6)  ·  Abscess (1)  ·  Bacteremia (1)  ·  Central Nervous System Infections (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Foot (1)  ·  Endocarditis (1)  ·  Mastoiditis (1)  ·  Orbital Cellulitis (1)  ·  Peritonsillar Abscess (1)  ·  Retropharyngeal Abscess (1)  ·  Staphylococcal Infections (1)

Broader conditions

Bone Diseases (12)  ·  Bone Diseases, Infectious (12)  ·  Infections (12)  ·  Musculoskeletal Diseases (12)  ·  Arthritis (6)  ·  Joint Diseases (6)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Cardiovascular Diseases (2)  ·  Endocrine System Diseases (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Suppuration (2)

Interventions

Cefazolin (3)  ·  Daptomycin (3)  ·  Ceftaroline (2)  ·  Vancomycin (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Ceftriaxone (1)  ·  Cloxacillin (1)  ·  Dicloxacillin (1)  ·  Injections (1)  ·  Linezolid (1)  ·  Monobactams (1)  ·  Nafcillin (1)  ·  Rifampin (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  dalbavancin (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Dr. Olivier Borens (1)  ·  Henry Ford Health System (1)  ·  Indiana University (1)  ·  Infectious Diseases Physicians, Inc. (1)  ·  Michael Garron Hospital (1)  ·  Murdoch Childrens Research Institute (1)  ·  Orlando Health, Inc. (1)  ·  University of Arizona (1)  ·  VA Office of Research and Development (1)  ·  Vancouver Island Health Authority (1)

Countries

United States (5)  ·  Canada (2)  ·  Australia (1)  ·  Denmark (1)  ·  Ireland (1)  ·  New Zealand (1)  ·  Switzerland (1)

Top investigators

Allan Bybeck Nielsen, MD (1)  ·  Amanda Gwee, PhD (1)  ·  Donald Poretz, MD (1)  ·  Eric Partlow, MD, FRCPC (1)  ·  James Wood, MD (1)  ·  Jose Vazquez, M.D. (1)  ·  Mark R. Wallace, MD (1)  ·  Mary T Bessesen, MD (1)  ·  Ulrikka Nygaard, Ass Prof PhD (1)

Results publications

PMID 31914940, PMID 37263683, PMID 39025092